Literature DB >> 32276945

Fibroblast Growth Factor 23 and the Last Mile.

Orlando M Gutiérrez1.   

Abstract

Entities:  

Keywords:  Diagnostic Tests; Fibroblast Growth Factors; Routine; cardiovascular disease; fibroblast growth factor 23; hyperphosphatemia; mineral metabolism

Mesh：

Substances：

Year:  2020        PMID： 32276945      PMCID： PMC7480560          DOI： 10.2215/CJN.13631119

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

Authors:  Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Eschenberg; William G Richards
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 3.  Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.

Authors:  Orlando M Gutiérrez
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

Review 4.  Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Authors:  Tamara Isakova; Joachim H Ix; Stuart M Sprague; Kalani L Raphael; Linda Fried; Jennifer J Gassman; Dominic Raj; Alfred K Cheung; John W Kusek; Michael F Flessner; Myles Wolf; Geoffrey A Block
Journal:  J Am Soc Nephrol       Date:  2015-05-12       Impact factor: 10.121

5.  Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Authors:  Sharon M Moe; Glenn M Chertow; Patrick S Parfrey; Yumi Kubo; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Maria Stolina; Bastian Dehmel; William G Goodman; Jürgen Floege
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

Review 6.  Cardiac actions of fibroblast growth factor 23.

Authors:  Christian Faul
Journal:  Bone       Date:  2016-10-07       Impact factor: 4.398

7.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

Review 8.  Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Authors:  Amarnath Marthi; Killian Donovan; Richard Haynes; David C Wheeler; Colin Baigent; Christopher M Rooney; Martin J Landray; Sharon M Moe; Jun Yang; Lisa Holland; Romina di Giuseppe; Annet Bouma-de Krijger; Borislava Mihaylova; William G Herrington
Journal:  J Am Soc Nephrol       Date:  2018-05-15       Impact factor: 10.121

9.  Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease.

Authors:  Jacob A Udell; David A Morrow; Petr Jarolim; Sarah Sloan; Elaine B Hoffman; Thomas F O'Donnell; Amit N Vora; Torbjørn Omland; Scott D Solomon; Marc A Pfeffer; Eugene Braunwald; Marc S Sabatine
Journal:  J Am Coll Cardiol       Date:  2014-04-09       Impact factor: 24.094

10.  Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.

Authors:  Valentin David; Aline Martin; Tamara Isakova; Christina Spaulding; Lixin Qi; Veronica Ramirez; Kimberly B Zumbrennen-Bullough; Chia Chi Sun; Herbert Y Lin; Jodie L Babitt; Myles Wolf
Journal:  Kidney Int       Date:  2016-01-04       Impact factor: 10.612
  10 in total
  1 in total

1.  FGF-23 and Phosphate in Children with Chronic Kidney Disease: A Cross-Sectional Study in Kazakhstan.

Authors:  Altynay Balmukhanova; Kairat Kabulbayev; Harika Alpay; Assiya Kanatbayeva; Aigul Balmukhanova
Journal:  Medicina (Kaunas)       Date:  2020-12-28       Impact factor: 2.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.